Faes Farma, S.A. (BME:FAE)
Spain
· Delayed Price · Currency is EUR 3.920
-0.080 (-2.00%)
Mar 31, 2025, 2:40 PM CET
Faes Farma Revenue
In the year 2024, Faes Farma had annual revenue of 510.04M EUR with 7.81% growth. Faes Farma had revenue of 117.13M in the quarter ending December 31, 2024, with 5.40% growth.
Revenue
510.04M
Revenue Growth
+7.81%
P/S Ratio
n/a
Revenue / Employee
289.47K
Employees
1,748
Market Cap
1.24B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 510.04M | 36.95M | 7.81% |
| Dec 31, 2023 | 473.09M | 11.38M | 2.46% |
| Dec 31, 2022 | 461.72M | 33.08M | 7.72% |
| Dec 31, 2021 | 428.64M | 17.15M | 4.17% |
| Dec 31, 2020 | 411.49M | 28.30M | 7.39% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Grifols | 7.21B |
| Laboratorios Farmaceuticos Rovi | 763.75M |
| Almirall | 990.63M |
| Pharma Mar | 174.86M |
| Clínica Baviera | 265.72M |
| Atrys Health | 211.11M |
| Laboratorio Reig Jofre | 338.90M |
| Oryzon Genomics | 7.36M |